Bolton Securities’s Virtus Biotech ETF BBP Stock Holding History
Bought
Maintained
Sold
Other funds holding BBP
Bolton Securities's BBP Position: Q3 2026 in Review
Bolton Securities increased its Virtus Biotech ETF (BBP) stake by 146% in Q3 2026, buying an estimated $126K and bringing the position to 2,073 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #862.
Bolton Securities first reported a position in BBP in Q4 2025 and has held it in 4 quarters since. 29 funds tracked by Wall St. Rank hold BBP as of Q3 2026.
- Bolton Securities held 2,073 shares of Virtus Biotech ETF worth $219K as of Q3 2026.
- Bolton Securities bought 1,230 Virtus Biotech ETF shares in Q3 2026, an estimated $126K.
- Virtus Biotech ETF made up 0.01% of Bolton Securities's portfolio in Q3 2026, its #862 holding.
- Bolton Securities first reported a position in Virtus Biotech ETF in Q4 2025 and has held it in 4 quarters since.
- 29 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2026.
Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.